Learn how to navigate cystic fibrosis care with confidence, from treatments and school plans to building a supportive medical ...

ReCode Therapeutics, a clinical-stage genetic medicines company using tissue-specific delivery to power the next wave of mRNA ...

("Owlstone"), the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today ...

ReCode’s lead programs include RCT2100 for the treatment of the 10% of people with cystic fibrosis who have genetic mutations in the CFTR gene that do not respond to currently approved CFTR ...

In collaboration with Medical Detection Dogs, a team at Imperial College London has discovered dogs can detect bacteria like ...

The Foundation’s funding will support Owlstone Medical’s development of a breath test to help doctors diagnose and monitor ...

Camp said this a great way to showcase the senior athletes as well as a way to give back to the Cystic Fibrosis Foundation.

Vertex Pharmaceuticals (NasdaqGS:VRTX) saw a notable 20.53% share price increase over the last quarter, which coincided with several key developments in its Type 1 Diabetes (T1D) initiatives. The ...

Ricky, 7, and Freya, 4, have been treated at Great Ormond Street Hospital in London after being diagnosed - read their story ...

A breath test would be less invasive than the traditional method of using mucus or phlegm samples from the lungs of cystic ...

Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and ...